...
首页> 外文期刊>European respiratory review >Comorbidities in interstitial lung diseases
【24h】

Comorbidities in interstitial lung diseases

机译:间质性肺疾病合并症

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Fibrosing lung disorders include a large number of diseases with diverse behaviour. Patients can die because of the progression of their illness; remain stable or even improve after appropriate treatment has been instituted. Comorbidities; such as acute and chronic infection; gastro-oesophageal reflux; pulmonary hypertension; lung cancer; cardiovascular diseases; and obstructive sleep apnoea; can pre-exist or develop at any time during the course of the disease and; if unidentified and untreated; may impair quality of life; impact upon the respiratory status of the patients; and ultimately lead to disease progression and death. Therefore; early identification and accurate treatment of comorbidities is essential.
机译:纤维化性肺部疾病包括多种行为多样的疾病。患者会因病情发展而死亡;在采取适当的治疗后保持稳定甚至改善。合并症;如急慢性感染;胃食管反流;肺动脉高压;肺癌;心血管疾病;和阻塞性睡眠呼吸暂停;可以在疾病过程中的任何时间预先存在或发展;以及如果身份不明并未经处理;可能会损害生活质量;对患者呼吸状态的影响;最终导致疾病发展和死亡。因此;早期发现并准确治疗合并症至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号